Back
Cyclo Therapeutics Vs. Pacira BioSciences Industry Stock Comparison
Sell
31
CYTH
Cyclo Therapeutics
Last Price:
0.59
Seasonality Move:
18.97%
Sell
47
PCRX
Pacira BioSciences
Last Price:
19.89
Seasonality Move:
12.01%
Sell
31
Cyclo Therapeutics (CYTH)
is a Sell
Is Cyclo Therapeutics a Buy, Sell or Hold?
- The current Cyclo Therapeutics [CYTH] share price is $0.58. The Score for CYTH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CYTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $19.86. The Score for PCRX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTH Stock Price Chart
What is Cyclo Therapeutics's stock price today?
-
The Cyclo Therapeutics share price today is $0.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTH is experiencing slight selling pressure.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $19.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CYTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 37.49 | Sell |
Chaikin Money Flow: | -14999 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.72) | Sell |
Bollinger Bands (100): | (0.62 - 1) | Sell |
PCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.83 | Buy |
Relative Strength Index (14 RSI): | 64.1 | Buy |
Chaikin Money Flow: | 553961 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.53 - 19.03) | Buy |
Bollinger Bands (100): | (14.02 - 18.88) | Buy |
CYTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.71 | Sell |
200-day SMA: | 1.08 | Sell |
8-day EMA: | 0.61 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.71 | Sell |
200-day EMA: | 1 | Sell |
PCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.48 | Buy |
20-day SMA: | 18 | Buy |
50-day SMA: | 17.25 | Buy |
200-day SMA: | 22.02 | Sell |
8-day EMA: | 19.34 | Buy |
20-day EMA: | 18.4 | Buy |
50-day EMA: | 17.55 | Buy |
200-day EMA: | 21.38 | Sell |
Cyclo Therapeutics Earnings Growth & CYTH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.19 per share.
Cyclo Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pacira BioSciences Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |